FDA Calendar for Alexza Pharmaceuticals, Inc. (ALXA)

| Register (free)
Alexza Pharmaceuticals, Inc. (Alexza) is a pharmaceutical company focused on the research, development, and commercialization of products for the acute treatment of central nervous system (CNS) conditions. The Company’s product candidates are based on its technology, the Staccato system. The Staccato system vaporizes an excipient-free drug to form a condensation aerosol that, when inhaled, allows for systemic drug delivery. Alexza has five other product candidates in various stages of clinical development. On August 26, 2009, Alexza completed the acquisition of Symphony Allegro, Inc.


Drug Pipeline

Drug NameType Of DrugFDA StatusDrug Phase
AZ-004 Other Pending DecisionNDA
AZ-001 Pain Management UnknownPhase 2
AZ-104 Pain Management UnknownPhase 2
AZ-003 Pain Management UnknownPhase 1
AZ-002 Other UnknownPhase 2
AZ-007 Other UnknownPhase 1


Events

Alexza Pharmaceuticals, Inc. 05/10/2010
Past Event
Earnings: Q1 - 2010 Earnings Release at 4PM.
Alexza Pharmaceuticals, Inc. 05/10/2010
Past Event
Earnings: Q1 - 2010 Earnings Release at 4PM.
Alexza Pharmaceuticals, Inc. 05/11/2010
Past Event
Presentation: Presentation at JMP Securities Research Conference.
Alexza Pharmaceuticals, Inc. 05/18/2010
Past Event
Meeting: 2010 Annual Meeting of Stockholders - 2:30PM PT
Alexza Pharmaceuticals, Inc. 10/11/2010
1 month(s)
FDA Decision: FDA decision date.
(relates to the drug AZ-004)

Add New Event

In order to write a comment you must first login.

Login or Register (for free!)

Add Event

Comments

No comments found.

Add New Comment

In order to write a comment you must first login.

Login or Register (for free!)

Add Comment

ALXA

$3.02
-0.06 -1.95%
9/3/2010 4:00:00 PM

Sponsors